CD5 and melanoma: Allelic combinations of the CD5 rs2241002 and rs2229177 SNPs resulting in hyper-reactivity to TCR stimulation are associated to more severe systemic lupus erythematosus (SLE) forms, but predict better prognosis in chronic lymphocytic leukemia (CLL) and melanoma (27–29).